Latin America Pharma Growth: Boehringer Ingelhe...

By HEOR Staff Writer

January 27, 2026

Latin America Pharma Growth is surging as a high-growth engine for Boehringer Ingelheim, with double-digit market expansions outpacing mature regions like Europe, according to
β-Blockers Myocardial Infarction: Reevaluating Their Role in Patients with Pr...
Bausch Health’s Strategic Growth in Latin American Pharmaceuticals Thro...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Weight Loss: Advances in Hormone-Based Obesity Treatments
Beta-Blockers in Heart Attack Recovery: Reevaluating Their Role Based on Rece...
CTX310 Lipid Disorder: Phase 1 Trial Shows Promising LDL and Triglyceride Red...
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...